Revisor Wealth Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Buy
1,012
+12
+1% +$2.66K 0.06% 333
2026
Q2
$211K Hold
1,000
– – 0.05% 353
2026
Q1
$221K Hold
1,000
– – 0.06% 302
2025
Q4
$260K Buy
1,000
+100
+11% +$25.1K 0.07% 265
2025
Q3
$215K Hold
900
– – 0.07% 256
2025
Q2
$208K Hold
900
– – 0.07% 258
2025
Q1
$204K Buy
+900
New +$198K 0.09% 212
2024
Q2
– Sell
-1,600
Closed -$356K – 188
2024
Q1
$356K Buy
+1,600
New +$361K 0.16% 147
2023
Q3
– Sell
-1,600
Closed -$360K – 173
2023
Q2
$360K Sell
1,600
-800
-33% -$160K 0.32% 78
2023
Q1
$459K Buy
+2,400
New +$464K 0.42% 58

Other funds holding STE

Revisor Wealth Management's STE Position: Q3 2026 in Review

Revisor Wealth Management increased its Steris (STE) stake by 1.2% in Q3 2026, buying an estimated $2.66K and bringing the position to 1,012 shares worth $224K. The position accounts for 0.06% of the portfolio, ranked #333.

Revisor Wealth Management first reported a position in STE in Q1 2023 and has held it in 10 quarters since. The position peaked at $459K in Q1 2023. 162 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • Revisor Wealth Management held 1,012 shares of Steris worth $224K as of Q3 2026.
  • Revisor Wealth Management bought 12 Steris shares in Q3 2026, an estimated $2.66K.
  • Steris made up 0.06% of Revisor Wealth Management's portfolio in Q3 2026, its #333 holding.
  • Revisor Wealth Management first reported a position in Steris in Q1 2023 and has held it in 10 quarters since.
  • Revisor Wealth Management's Steris position peaked at $459K in Q1 2023.
  • 162 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on Revisor Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.